ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,683,000 | +343.9% | 380,713 | +202.2% | 0.02% | +350.0% |
| Q2 2017 | $1,055,000 | +5.6% | 125,993 | +12.8% | 0.00% | 0.0% |
| Q1 2017 | $999,000 | -18.4% | 111,739 | -19.8% | 0.00% | -20.0% |
| Q4 2016 | $1,224,000 | +41.8% | 139,267 | +9.0% | 0.01% | +25.0% |
| Q3 2016 | $863,000 | +166.4% | 127,788 | +40.2% | 0.00% | +300.0% |
| Q2 2016 | $324,000 | +20.4% | 91,127 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $269,000 | -31.0% | 91,127 | -1.5% | 0.00% | -50.0% |
| Q4 2015 | $390,000 | -6.5% | 92,527 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $417,000 | -36.8% | 91,543 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $660,000 | -6.6% | 91,543 | -4.5% | 0.00% | 0.0% |
| Q1 2015 | $707,000 | +56.8% | 95,884 | +0.5% | 0.00% | +50.0% |
| Q4 2014 | $451,000 | +29.6% | 95,385 | -2.1% | 0.00% | +100.0% |
| Q3 2014 | $348,000 | -22.0% | 97,478 | -0.4% | 0.00% | -50.0% |
| Q2 2014 | $446,000 | -0.9% | 97,910 | +2.3% | 0.00% | 0.0% |
| Q1 2014 | $450,000 | -22.0% | 95,753 | -16.8% | 0.00% | 0.0% |
| Q4 2013 | $577,000 | -17.8% | 115,135 | +2.1% | 0.00% | -33.3% |
| Q3 2013 | $702,000 | +74.2% | 112,808 | +27.1% | 0.00% | +50.0% |
| Q2 2013 | $403,000 | – | 88,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |